Skip to content
About CombiGene
Projects
The Pain Program COZY
The epilepsy project CG01
The lipodystrophy project CGT2
Patent
The Market
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Organization
Articles of association
Company description
IR-contact
Certified Adviser
Media
Press releases
Presentations
Ingeneious
Calendar
Contact
Contact us
Downloads
About CombiGene
Projects
The Pain Program COZY
The epilepsy project CG01
The lipodystrophy project CGT2
Patent
The Market
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Organization
Articles of association
Company description
IR-contact
Certified Adviser
Media
Press releases
Presentations
Ingeneious
Calendar
Contact
Contact us
Downloads
SV
Financial calendar
February 17, 2023
Year-end report 2022
May 12, 2023
Interim report January-March 2023
May 25, 2023
Annual General meeting 2023
August 25, 2023
Interim report January-June 2023
November 10, 2023
Interim report January-September 2023
February 16, 2024
Year-end report 2023
Financial reports
May 12, 2023
Interim report January – March 2023 for CombiGene AB (publ)
April 26, 2023
CombiGene AB (publ) publishes annual report for 2022
February 17, 2023
Year-end report January-December 2022 CombiGene AB (Publ)
November 11, 2022
Interim report January – September 2022 for CombiGene AB (publ)
August 25, 2022
Interim report January – June 2022 for CombiGene AB (publ)
May 12, 2022
Interim report January – March 2022 for CombiGene AB (publ)
Load more
